首页 | 本学科首页   官方微博 | 高级检索  
     

沙库巴曲缬沙坦钠片联合百令胶囊治疗慢性左心衰竭合并肾功能不全的临床观察
引用本文:张亚玲,李明,谭刚,李小平,黄慧. 沙库巴曲缬沙坦钠片联合百令胶囊治疗慢性左心衰竭合并肾功能不全的临床观察[J]. 中国药房, 2021, 0(6): 720-724
作者姓名:张亚玲  李明  谭刚  李小平  黄慧
作者单位:四川省医学科学院·四川省人民医院肾内科;四川省医学科学院·四川省人民医院心内科
基金项目:四川省重点研发项目(No.19ZDYF0669);四川省卫生和计划生育委员会科研项目(No.16PJ425)。
摘    要:目的:研究沙库巴曲缬沙坦钠片联合百令胶囊治疗慢性左心衰竭合并肾功能不全患者的疗效及安全性,为临床用药提供参考.方法:将2018年11月至2019年11月于四川省人民医院就诊的96例慢性左心衰竭合并肾功能不全患者根据随机数字表法分为A、B、C组,每组32例.A组患者给予常规抗心力衰竭治疗和百令胶囊(每次2 g,每日3次)...

关 键 词:慢性左心衰竭  肾功能不全  沙库巴曲缬沙坦钠片  百令胶囊  临床疗效  安全性

Clinical Observation of Sacubitril Valsartan Sodium Tablets Combined with Bailing Capsules in the Treatment of Chronic Left Heart Failure with Renal Insufficiency
ZHANG Yaling,LI Ming,TAN Gang,LI Xiaoping,HUANG Hui. Clinical Observation of Sacubitril Valsartan Sodium Tablets Combined with Bailing Capsules in the Treatment of Chronic Left Heart Failure with Renal Insufficiency[J]. China Pharmacy, 2021, 0(6): 720-724
Authors:ZHANG Yaling  LI Ming  TAN Gang  LI Xiaoping  HUANG Hui
Affiliation:(Dept.of Nephrology,Sichuan Academy of Medical Science&Sichuan Provincial People’s Hospital,Chengdu 610072,China;Dept.of Cardiology,Sichuan Academy of Medical Science&Sichuan Provincial People’s Hospital,Chengdu 610072,China)
Abstract:OBJECTIVE:To study the efficacy and safety of sacubitril valsartan sodium tablets combined with Bailing capsules in the treatment of chronic left heart failure with renal insufficiency,and to provide reference for clinical drug use.METHODS:Totally 96 patients with chronic left heart failure with renal insufficiency who sought medical care in our hospital from Nov.2018 to Nov.2019 were divided into group A,B and C according to table of random numbers,with 32 cases in each group.Group A received conventional heart failure treatment and and Bailing capsules(2 g each time,3 times a day);group B received conventional heart failure treatment and Sacubitril valsartan sodium tablets(50 mg each time,twice a day);group C was given with heart failure treatment and Sacubitril valsartan sodium tablets(50 mg each time,twice a day)and Bailing capsules(2 g each time,3 times a day).3 groups received consecutive 6 months of treatment.Clinical response rates of 3 groups were compared.Left heart function indexes[left ventricular end systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF)]and serological indexes[interleukin 1(IL-1),IL-6,N terminal brain natriuretic peptide precursor,glomerular filtration rate(GFR)]were detected before and after treatment.The occurrence of ADR were observed and recorded.RESULTS:During this study,a total of 6 patients fell off,and eventually 90 patients completed the study,including 29 cases in group A,30 cases in group B and 31 cases in group C.Before treatment,there was no statistical significance in left heart function indexes or serological indexes among 3 groups(P>0.05).After 6 months of treatment,clinical response rate of group C was significantly higher than those of group A and B(P<0.05).Compared with before treatment,LVEDD,LVESD and serological indexes of 3 groups were decreased significantly after treatment(P<0.05),while LVEF and GFRwere increased significantly(P<0.05);the changes of above indexes(except for IL-1 level in serum)in group C were significantly better than group A and B,the changes of above indexes in group B(except for GFR)were significantly better than group A(P<0.05).No significant ADR were observed in 3 groups.CONCLUSIONS:Sacubitril valsartan sodium tablets combined with Bailing capsules can significantly decrease the level of serum inflammation factors,and improve cardiac and renal function in patients with chronic left heart failure with renal insufficiency,with good safety.
Keywords:Chronic left heart failure  Renal insufficiency  Sacubitril valsartan sodium tablets  Bailing capsules  Clinical efficacy  Safety
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号